AFP and hepatocellular carcinoma: Through a multicenter cross-sectional study, a biomarker combination consisting of Phe-Trp and GCA was identified and used as a test for hepatocellular carcinoma (HCC), and they were further developed as an effective tool to verify AFP false-negative HCC patients and high-risk S-HCC patients [23].